Block copolymeric biotransport carriers as versatile vehicles for drug delivery

被引:56
作者
Alakhov, V
Klinski, E
Lemieux, P
Pietrzynski, G
Kabanov, A
机构
[1] Supratek pharma Inc, Laval, PQ H7B 1B7, Canada
[2] Univ Nebraska, Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA
关键词
biological response modifying agent; block copolymers; combinatorial chemistry; drug delivery; micelles;
D O I
10.1517/14712598.1.4.583
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This review describes block copolymer-based systems that are used in drug formulation development. The use of amphiphilic block copolymers to modify pharmacological performance of various classes of drugs attracts more and more attention. This is largely attributable to the high tendency of block copolymer-based drug formulations to self-assemble, as well as flexibility of block copolymer chemistry, which allows precise tailoring of the carrier to virtually any chemical entity. Combination of these features allows adjustment of block copolymer-based drug formulations to achieve the most beneficial balance in drug biological interactions with the systems that control its circulation in and removal from the body and its therapeutic activity. The following major aspects are considered: 1) physical properties of formulations and the methods used to adjust these properties towards the highest pharmacological performance of the product; 2) combinatorial methods for optimisation of block copolymer-based formulations; 3) biological response modifying properties of block copolymer-based formulations.
引用
收藏
页码:583 / 602
页数:20
相关论文
共 126 条
  • [61] QSPR - THE CORRELATION AND QUANTITATIVE PREDICTION OF CHEMICAL AND PHYSICAL-PROPERTIES FROM STRUCTURE
    KATRITZKY, AR
    LOBANOV, VS
    KARELSON, M
    [J]. CHEMICAL SOCIETY REVIEWS, 1995, 24 (04) : 279 - +
  • [62] Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin.: II.: Micelle formation and drug release behaviours
    Kim, SY
    Shin, ILG
    Lee, YM
    Cho, CS
    Sung, YK
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 51 (01) : 13 - 22
  • [63] Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide)
    Kohori, F
    Sakai, K
    Aoyagi, T
    Yokoyama, M
    Sakurai, Y
    Okano, T
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 55 (01) : 87 - 98
  • [64] Block copolymer micelles for drug delivery: loading and release of doxorubicin
    Kwon, G
    Naito, M
    Yokoyama, M
    Okano, T
    Sakurai, Y
    Kataoka, K
    [J]. JOURNAL OF CONTROLLED RELEASE, 1997, 48 (2-3) : 195 - 201
  • [65] Polymeric micelles as new drug carriers
    Kwon, GS
    Okano, T
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1996, 21 (02) : 107 - 116
  • [66] PHYSICAL ENTRAPMENT OF ADRIAMYCIN IN AB BLOCK-COPOLYMER MICELLES
    KWON, GS
    NAITO, M
    YOKOYAMA, M
    OKANO, T
    SAKURAI, Y
    KATAOKA, K
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (02) : 192 - 195
  • [67] BLOCK-COPOLYMER MICELLES AS LONG-CIRCULATING DRUG VEHICLES
    KWON, GS
    KATAOKA, K
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) : 295 - 309
  • [68] KWON GS, 1998, ADV DRUG DELIVERY RE, V16, P295
  • [69] Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles
    La, SB
    Okano, T
    Kataoka, K
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (01) : 85 - 90
  • [70] Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study
    Laham, RJ
    Chronos, NA
    Pike, M
    Leimbach, ME
    Udelson, JE
    Pearlman, JD
    Pettigrew, RI
    Whitehouse, MJ
    Yoshizawa, C
    Simons, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2132 - 2139